Business
CSL (ASX:CSL) share price on watch after terminating COVID-19 vaccine trial
The CSL Limited (ASX: CSL) share price will be one to watch on Friday after the release of an update on its COVID-19 vaccine candidate.
What did CSL announce?
This morning CSL and the University of Queensland (UQ) announced results from the Phase 1 trial of the UQ-CSL v451 COVID-19 vaccine.
According to the release, the vaccine has shown that it elicits a robust response towards the virus and has a strong safety profile.
And while there were no serious adverse events or safety concerns reported, following agreement with the Australian Government, CSL will not progress the vaccine candidate to Phase 2/3 clinical trials.
Why is it not going any further?
The release explains that the Phase 1 data showed the generation of antibodies…
-
Noosa News21 hours agoChef Sophie Phipps prepares to open restaurant at 30-acre Alsahwa Estate
-
General13 hours ago‘Sovereign citizens’ sentenced to prison term in Western Australia for defiance of court order
-
General7 hours agoAbattoir worker in serious condition after workplace accident in Echuca
-
Noosa News19 hours agoSpectacles of Wonder